Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys

Susan M. Carlton, Huw Rees, Masayoshi Tsuruoka, William D. Willis

    Research output: Contribution to journalArticle

    18 Citations (Scopus)

    Abstract

    Several lines of evidence indicate that N-methyl-D-aspartate (NMDA) receptors play an important role in nociception in general and in pathological pain in particular. It has been previously demonstrated in behavioral studies that NMDA receptor antagonists attenuate pathological pain in humans and nociceptive behaviors in animals. In the present study, we investigated the effect of the NMDA receptor antagonist memantine (MEM) on the responses of spinothalamic tract (STT) cells in normal and neuropathic monkeys. Memantine was delivered into the spinal cord through a microdialysis fiber acutely implanted into the dorsal horn. Responses of STT cells to peripheral stimulation within their receptive fields were recorded before and after MEM infusion. In normal animals (n = 7), 10 mM MEM did not affect STT cell (n = 7) baseline activity or responses to mechanical stimuli (brush, press or pinch). In neuropathic animals (n=6), 1.0, 3.0, 10.0 and 100 mM MEM did not affect baseline activity of STT cells (n=7); however, in a dose- dependent fashion, it significantly reduced responses of these cells to all cutaneous stimuli. The data suggest that MEM can have a direct effect on STT cells, blocking NMDA receptors known to be present on this cell population and, furthermore, may be a therapeutic agent for chronic pain.

    Original languageEnglish (US)
    Pages (from-to)229-238
    Number of pages10
    JournalEuropean Journal of Pain
    Volume2
    Issue number3
    DOIs
    StatePublished - 1998

    Fingerprint

    Spinothalamic Tracts
    Memantine
    Haplorhini
    Skin
    N-Methyl-D-Aspartate Receptors
    Pain
    Animal Behavior
    Nociception
    Microdialysis
    Chronic Pain
    Spinal Cord

    ASJC Scopus subject areas

    • Anesthesiology and Pain Medicine
    • Neurology
    • Neuropsychology and Physiological Psychology

    Cite this

    Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys. / Carlton, Susan M.; Rees, Huw; Tsuruoka, Masayoshi; Willis, William D.

    In: European Journal of Pain, Vol. 2, No. 3, 1998, p. 229-238.

    Research output: Contribution to journalArticle

    Carlton, Susan M. ; Rees, Huw ; Tsuruoka, Masayoshi ; Willis, William D. / Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys. In: European Journal of Pain. 1998 ; Vol. 2, No. 3. pp. 229-238.
    @article{e51351357f294a99bbc4d698a7f3ca0a,
    title = "Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys",
    abstract = "Several lines of evidence indicate that N-methyl-D-aspartate (NMDA) receptors play an important role in nociception in general and in pathological pain in particular. It has been previously demonstrated in behavioral studies that NMDA receptor antagonists attenuate pathological pain in humans and nociceptive behaviors in animals. In the present study, we investigated the effect of the NMDA receptor antagonist memantine (MEM) on the responses of spinothalamic tract (STT) cells in normal and neuropathic monkeys. Memantine was delivered into the spinal cord through a microdialysis fiber acutely implanted into the dorsal horn. Responses of STT cells to peripheral stimulation within their receptive fields were recorded before and after MEM infusion. In normal animals (n = 7), 10 mM MEM did not affect STT cell (n = 7) baseline activity or responses to mechanical stimuli (brush, press or pinch). In neuropathic animals (n=6), 1.0, 3.0, 10.0 and 100 mM MEM did not affect baseline activity of STT cells (n=7); however, in a dose- dependent fashion, it significantly reduced responses of these cells to all cutaneous stimuli. The data suggest that MEM can have a direct effect on STT cells, blocking NMDA receptors known to be present on this cell population and, furthermore, may be a therapeutic agent for chronic pain.",
    author = "Carlton, {Susan M.} and Huw Rees and Masayoshi Tsuruoka and Willis, {William D.}",
    year = "1998",
    doi = "10.1016/S1090-3801(98)90019-2",
    language = "English (US)",
    volume = "2",
    pages = "229--238",
    journal = "European Journal of Pain",
    issn = "1090-3801",
    publisher = "W.B. Saunders Ltd",
    number = "3",

    }

    TY - JOUR

    T1 - Memantine attenuates responses of spinothalamic tract cells to cutaneous stimulation in neuropathic monkeys

    AU - Carlton, Susan M.

    AU - Rees, Huw

    AU - Tsuruoka, Masayoshi

    AU - Willis, William D.

    PY - 1998

    Y1 - 1998

    N2 - Several lines of evidence indicate that N-methyl-D-aspartate (NMDA) receptors play an important role in nociception in general and in pathological pain in particular. It has been previously demonstrated in behavioral studies that NMDA receptor antagonists attenuate pathological pain in humans and nociceptive behaviors in animals. In the present study, we investigated the effect of the NMDA receptor antagonist memantine (MEM) on the responses of spinothalamic tract (STT) cells in normal and neuropathic monkeys. Memantine was delivered into the spinal cord through a microdialysis fiber acutely implanted into the dorsal horn. Responses of STT cells to peripheral stimulation within their receptive fields were recorded before and after MEM infusion. In normal animals (n = 7), 10 mM MEM did not affect STT cell (n = 7) baseline activity or responses to mechanical stimuli (brush, press or pinch). In neuropathic animals (n=6), 1.0, 3.0, 10.0 and 100 mM MEM did not affect baseline activity of STT cells (n=7); however, in a dose- dependent fashion, it significantly reduced responses of these cells to all cutaneous stimuli. The data suggest that MEM can have a direct effect on STT cells, blocking NMDA receptors known to be present on this cell population and, furthermore, may be a therapeutic agent for chronic pain.

    AB - Several lines of evidence indicate that N-methyl-D-aspartate (NMDA) receptors play an important role in nociception in general and in pathological pain in particular. It has been previously demonstrated in behavioral studies that NMDA receptor antagonists attenuate pathological pain in humans and nociceptive behaviors in animals. In the present study, we investigated the effect of the NMDA receptor antagonist memantine (MEM) on the responses of spinothalamic tract (STT) cells in normal and neuropathic monkeys. Memantine was delivered into the spinal cord through a microdialysis fiber acutely implanted into the dorsal horn. Responses of STT cells to peripheral stimulation within their receptive fields were recorded before and after MEM infusion. In normal animals (n = 7), 10 mM MEM did not affect STT cell (n = 7) baseline activity or responses to mechanical stimuli (brush, press or pinch). In neuropathic animals (n=6), 1.0, 3.0, 10.0 and 100 mM MEM did not affect baseline activity of STT cells (n=7); however, in a dose- dependent fashion, it significantly reduced responses of these cells to all cutaneous stimuli. The data suggest that MEM can have a direct effect on STT cells, blocking NMDA receptors known to be present on this cell population and, furthermore, may be a therapeutic agent for chronic pain.

    UR - http://www.scopus.com/inward/record.url?scp=0031691817&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0031691817&partnerID=8YFLogxK

    U2 - 10.1016/S1090-3801(98)90019-2

    DO - 10.1016/S1090-3801(98)90019-2

    M3 - Article

    VL - 2

    SP - 229

    EP - 238

    JO - European Journal of Pain

    JF - European Journal of Pain

    SN - 1090-3801

    IS - 3

    ER -